• Bullous pemphigoid
  • Smith-Magenis Syndrome, Potocki-Lupski Syndrome (17p11.2 Duplication/Deletion)
  • Erythropoietin Receptor (EPOR) Gene Mutation Analysis
  • Alveolar Rhabdomyosarcoma (ARMS), 13q14 (FOXO1 or FKHR) Rearrangement, FISH, Tissue
  • Influenza Virus Type A and B, Culture
  • Cerebrospinal Fluid Microscopic Evaluation, Cell Count and Differentiation
  • Cytochrome P450 2E1 (CYP2E1) Genotyping
  • Calcitonin, Fine-Needle Aspiration Biopsy Needle Wash
  • Malaria
  • Dehydroepiandrosterone Sulfate (DHEA-S)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis is restricted.